Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-01-13 @ 10:12 PM
Study NCT ID:
NCT00763568
Status:
COMPLETED
Last Update Posted:
2008-10-01
First Post:
2008-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Sponsor:
Romark Laboratories L.C.
Organization: